Dr. Agarwal Group of Eye Hospitals Raises Rs. 270 Crore Funding from Temasek for Investment, Expansion and Acquisition Plans

(L-R) Dr. Adil Agarwal, CEO and Prof. (Dr.) Amar Agarwal, (MS, FRCS, FRC Ophth), Chairman Dr. Agarwal Group of Eye Hospitals Raises Rs. 270 Crore Funding from Temasek for Investment, Expansion and Acquisition Plans Chennai, 13th February 2019: Dr. Agarwal’s Healthcare Ltd. (DAHCL) has raised Rs. 270 crore investment from Temasek, a global investment company headquartered in Singapore. The investment will be used to expand the Indian geographical footprint of the international eye care chain, along with significant investments in latest technology for super specialty eye-care. Temasek is a global investor anchored in Asia, with India accounting for around 4% of its S$308 billion (US$235b) portfolio as at 31 March 2018. Temasek‘s healthcare portfolio in India includes investments in Medanta MediCity, Manipal Hospitals and HealthCare Global. “The Agarwal Group is excited to welcome Temasek as an investor. We believe their expertise and support will hel...